NPM1 and acute promyelocytic leukemia: Whether these findings in the Indian population contribute to understanding the mechanisms of APL-like presentations in NPM1-mutated patients or if there are biases in the study, such as contamination of NPM1-mutated samples or differences in NPM1 mutation detection techniques[4] remains unclear.